923283-63-0 Usage
Description
1-tert-Butyl 3-Methyl 4-aMino-1H-pyrazole-1,3-dicarboxylate is a pyrazole-based chemical compound featuring a tert-butyl, a methyl, and an amino group attached to the pyrazole ring, along with two carboxylate groups. It is a versatile building block in organic synthesis with potential applications in pharmaceutical research and development, as well as in the synthesis of other organic compounds.
Uses
Used in Pharmaceutical Research and Development:
1-tert-Butyl 3-Methyl 4-aMino-1H-pyrazole-1,3-dicarboxylate is used as a building block for the development of new pharmaceutical compounds due to its unique structural features and potential for further chemical modifications.
Used in Organic Synthesis:
1-tert-Butyl 3-Methyl 4-aMino-1H-pyrazole-1,3-dicarboxylate is used as a key intermediate in the synthesis of various organic compounds, leveraging its reactive functional groups for the formation of new chemical entities.
Used in Chemical Research:
1-tert-Butyl 3-Methyl 4-aMino-1H-pyrazole-1,3-dicarboxylate is utilized in chemical research to explore its reactivity, stability, and potential interactions with other molecules, providing insights into its properties and applications.
Note: The specific applications and reasons for using 1-tert-Butyl 3-Methyl 4-aMino-1H-pyrazole-1,3-dicarboxylate in different industries would need to be further studied and investigated to fully understand its potential and limitations.
Check Digit Verification of cas no
The CAS Registry Mumber 923283-63-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,2,8 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 923283-63:
(8*9)+(7*2)+(6*3)+(5*2)+(4*8)+(3*3)+(2*6)+(1*3)=170
170 % 10 = 0
So 923283-63-0 is a valid CAS Registry Number.
923283-63-0Relevant articles and documents
Pyrazolo pyrimidines useful as aurora kinase inhibitors
-
Page/Page column 84-85, (2010/11/25)
The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
